Results 1 to 10 of about 994,937 (217)

Motor Vehicle Driving‐Related Anxiety in Patients Undergoing Cardioverter Defibrillator Implantation and Cardiac Resynchronization Therapy With Defibrillators [PDF]

Annals of Noninvasive Electrocardiology
Background Reducing anxiety about motor vehicle driving in patients receiving implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillators is important not only for improving quality of life but also for preventing ...
Shingo Moriguchi, Masahito Hitosugi, Yuzo Takeuchi, Takeshi Inoue, Shinsaku Takeda, Mineko Baba, Arisa Takeda, Mami Nakamura, Yasutaka Inuzuka   +8 more
doaj   +2 more sources

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan

Global Heart, 2022
Background and Objectives: Implantation of implantable cardioverter-defibrillators (ICD) has increased significantly over the past decade. However, limited data exist regarding practices and policies of ICD implantations in Kazakhstan.
Temirkhan Begisbayev, Lyazzat Kosherbayeva, Valikhan Akhmetov, Dmitry Khvan, Marzhan Brimzhanova   +4 more
doaj   +3 more sources

EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS

Europace, 2021
With the global increase in device implantations, there is a growing need to train physicians to implant pacemakers and implantable cardioverter-defibrillators.
H. Burri, C. Starck, A. Auricchio, M. Biffi, Mafalda Burri, André d'Avila, J. Deharo, M. Glikson, C. Israel, C. Lau, C. Leclercq, C. Love, J. Nielsen, K. Vernooy, N. Dagres, S. Boveda, C. Butter, É. Marijon, F. Braunschweig, G. Mairesse, M. Gleva, P. Defaye, F. Zanon, Nestor Lopez-Cabanillas, J. Guerra, V. Vassilikos, M. Martins Oliveira   +26 more
semanticscholar   +1 more source

Comparison of Anxiety and Depression Symptoms in Individuals According to their Sex, Type of Cardiac Device, and Diagnosis of Chagas Disease

Brazilian Journal of Cardiovascular Surgery, 2022
Introduction: Implantable cardiac pacemakers or cardioverter defibrillators are alternatives for the treatment of arrhythmias, however, their use has caused changes in the emotional state of patients.
Carina Aparecida Marosti Dessotte, Elisa Maia de Oliveira Grotti, Isabelle Brigliadori Ignácio, Paolla Algarte Fernandes, Suellen Rodrigues de Oliveira Maier, Lidia Aparecida Rossi, Rosana Aparecida Spadoti Dantas   +6 more
doaj   +1 more source

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Sensors, 2021
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to ...
Dominic A. M. J. Theuns, Sumant P. Radhoe, Jasper J. Brugts   +2 more
doaj   +1 more source

External defibrillation on an implantable defibrillator [PDF]

Journal of Anesthesia, 2013
To the Editor: Despite the best efforts of healthcare providers, guideline-conform treatment failure is expected to occur, particularly in real-world emergency situations [1]. In the case reported here, a 79-year-old man with a history of coronary artery disease and implantation of a cardioverter defibrillator (ICD) presented to the emergency room with
Fani Zagkli, Dimitrios Alexopoulos, John Chiladakis   +2 more
openaire   +2 more sources

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

New England Journal of Medicine, 1997
BACKGROUND Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be treated with either an implantable cardioverter-defibrillator or antiarrhythmic drugs, but the relative efficacy of these two ...
J. Mcanulty, B. Halperin, J. Kron, G. Larsen, M. Rait, R. Swenson, R. Floreck, C. Marchant, M. Hamlin, G. Heywood, P. Friedman, W. Stevenson, M. Swat, L. Ganz, M. Sweeney, J. Shea, J. Steinberg, F. Ehlert, S. Zelenkofstke, E. Menchavez-Tan, M. Stefano, G. Brown, L. Karagounis, B. Crandall, J. Osborn, D. Rawling, K. Summers, M. Jacobsen, J. Herre, R. Bernsteim, L. Klevan, D. Cannom, A. Bhandari, R. Lerman, B. Firth, R. Klein, R. Freedman, M. Marks, M. Delahunty, C. Spratt, R. Marinchak, S. Rials, P. Kowey, R. Fillart, M. Hernández, D. Scher, L. Zukerman, S. Farrell, J. Cross, J. Shewchjik, A. Epstein, R. Cooper, R. Dailey, S. M. Dailey, G. Kay, V. Plumb, R. Bubien, S. Knotts-Dolson, P. Mckenna, C. Tidwell, S. Kim, J. Fisher, K. Ferrick, J. Gross, U. Ben-Zur, J. Durkin, A. Ferrick, K. Beckman, J. McClelland, M. González, L. Widman, R. Lane, T. Deaton, J. Foster, G. Straughan, L. Wade, M. Brodsky, B. Allen, S. Ehrlich, L. Wolff, M. Macari-Hinson, J. Coromilas, T. Bigger, F. Livelli, J. Reiffel, K. Hickey, T. Akiyama, J. Daubert, C. Kim, D. Switzer, P. Pande, D. Flynn, M. Keller, C. Ocampo, K. Wahl, J. Vogt, S. Kutalek, S. Hessen, C. Movsowitz   +98 more
semanticscholar   +1 more source

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)

Вестник анестезиологии и реаниматологии, 2018
The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators.
N. V. Melnik
doaj   +1 more source

Is defibrillation testing required for defibrillator implantation?

Journal of the American College of Cardiology, 2004
The assessment of defibrillation (DFT) efficacy has long been the standard of care during defibrillator implantation. To ensure an acceptable DFT safety margin, early defibrillator systems frequently required that the shock polarity and the location, type, or number of electrodes had to be altered.
George J Klein, S. Adam Strickberger
openaire   +3 more sources